Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

TBI based VS chemotherapy based myeloablative conditioning in T cell replete haploidentical transplant

Yanal Alnimer, Murad Aldarayseh, Hiffsa Taj, Zena Chahine, Reinhold Munker, Gregory Monohan, Chaitanya Iragavarapu, Fevzi Yalniz, Ayman Qasrawi

Blood (2025) 146 (Supplement 1): 2442.

https://doi.org/10.1182/blood-2025-2442

Published: 2025

Journal Articles

Ziftomenib in combination with venetoclax and azacitidine in newly diagnosed NPM1-m acute myeloid leukemia: Phase 1b results from KOMET-007

Blood (2025) 146 (Supplement 1): 766.

https://doi.org/10.1182/blood-2025-766

Published: 2025

Journal Articles

Beyond age: Genomic features and treatment outcomes in older versus younger adults with Acute Myeloid Leukemia

Hardik Dand, Yanal Alnimer, Rafeh Safdar, Jonah Heidel, Cole Blanford, Chandra Kakarala, Ayman Qasrawi, Gregory Monohan, Reinhold Munker, Chaitanya Iragavarapu, Zena Chahine, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 3380.

https://doi.org/10.1182/blood-2025-3380

Published: 2025

Journal Articles

Outcomes with liposomal daunorubicin/cytarabine – a single-center experience

Jonah Heidel, Rafeh Safdar, Cole Blanford, Chandra Kakarala, Hardik Dand, Yanal Alnimer, Ayman Qasrawi, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 6973.

https://doi.org/10.1182/blood-2025-6973

Published: 2025

Journal Articles

Genetic risk model to predict outcomes for AML treated with HMA and venetoclax

Rafeh Safdar, Chandra Kakarala, Jonah Heidel, Cole Blanford, Hardik Dand, Yanal Alnimer, Ayman Qasrawi, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 1708.

https://doi.org/10.1182/blood-2025-1708

Published: 2025

Journal Articles

Prognostic impact of co-occurring mutations in NPM1-mutated Acute Myeloid Leukemia

Cole Blanford, Rafeh Safdar, Jonah Heidel, Chandra Kakarala, Hardik Dand, Yanal Alnimer, Ayman Qasrawi, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 1729.

https://doi.org/10.1182/blood-2025-1729

Published: 2025

Journal Articles

Impact of induction regimen and co-mutations on outcomes in AML with myelodysplasia-related changes

Yanal Alnimer, Rafeh Safdar, Hardik Dand, Cole Blanford, Jonah Heidel, Kakrala Chandra, Zena Chahine, Chaitanya Iragavarapu, Gregory Monohan, Reinhold Munker, Ayman Qasrawi, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 7034.

https://doi.org/10.1182/blood-2025-7034

Published: 2025

Journal Articles

Efficacy and safety of clia plus venetoclax as salvage therapy for relapsed or refractory Acute Myeloid Leukemia

Sarah Sertich, Brent Harris, Yanal Alnimer, Rafeh Safdar, Gregory Monohan, Zena Chahine, Reinhold Munker, Chaitanya Iragavarapu, Ayman Qasrawi, Fevzi Yalniz

Blood (2025) 146 (Supplement 1): 3454.

https://doi.org/10.1182/blood-2025-3454

Published: 2025

Journal Articles

Appropriate Timing of Allogeneic Bone Marrow Transplant in Patients with Myelodysplastic Syndrome

Yanal Alnimer, Reinhold Munker, Ayman Qasrawi, Gregory Monohan, Chait Iragavarapu, Fevzi Yalniz

Blood (2024) 144 (Supplement 1): 4605.

https://doi.org/10.1182/blood-2024-210157

Published: 2024

Journal Articles

Outcomes of Rituximab and Bendamustine Induction Regimen VS Cytarabine-Based Induction for Patients with Mantle Cell Lymphoma

Yanal Alnimer, Fevzi Yalniz, Gregory Monohan, Reinhold Munker, Ayman Qasrawi, Chait Iragavarapu, Mahmoud Amr

Blood (2024) 144 (Supplement 1): 6320.

https://doi.org/10.1182/blood-2024-211992

Published: 2024

Journal Articles

Gilteritinib Results in Higher Remission and Transplant Rates Than Midostaurin but Does Not Increase the Post-Induction Mutational MRD Negative Rate: Results of the Phase 2 Randomized Precog 0905 Study in Newly Diagnosed FLT3 Mutated AML

Blood (2024) 144 (Supplement 1): 221.

https://doi.org/10.1182/blood-2024-201595

Published: 2024

Journal Articles

Efficacy of Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm, an Interrupted Time Series Analysis

Yanal Alnimer, Moaath K. Mustafa Ali, Ayman Qasrawi, Fevzi Yalniz, Gregory Monohan, Chait Iragavarapu

Blood (2024) 144 (Supplement 1): 6016.

https://doi.org/10.1182/blood-2024-212229

Published: 2024

Journal Articles

Hyperbaric Oxygen (HBO) Effects on Blood Count Recovery and Post Transplant Outcomes Following High-Dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma: Final Analysis of the Multicenter Phase II Randomized Clinical Trial

Leyla O. Shune, Ayman Qasrawi, Gerhard C Hildebrandt, Eric J Huselton, Howard Langstein, Dennis Allin, Kaitlyn Burrows, Andrea M Baran, Jane L. Liesveld, Neil Blumberg, Brea Lipe, Andrew G Evans, Derick R Peterson, Omar Aljitawi

Blood (2024) 144 (Supplement 1): 4741.

https://doi.org/10.1182/blood-2024-211184

Published: 2024

Journal Articles

Hyperbaric Oxygen (HBO) Effects on Blood Count Recovery and Post-Transplant Outcomes Following High-Dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma: A Multicenter Phase II Randomized Clinical Trial

Leyla Shune, Ayman Qasrawi, Gerhard Hildebrandt, Eric J Huselton, Howard Langstein, Dennis Allin, Kaitlyn Burrows, Andrea M Baran, Jane L. Liesveld, Neil Blumberg, Brea Lipe, Andrew G Evans, Derick R Peterson, Omar Aljitawi

Blood (2023) 142 (Supplement 1): 2221.

https://doi.org/10.1182/blood-2023-190079

Published: 2023

Journal Articles

A Comparison of Somatic Mutations and ELN Classification in De Novo Acute Myeloid Leukemia between Appalachian and Non-Appalachian Kentucky

Zena Chahine, Xitong Zhou, Anna Johnson, Trevor Morris, Ashley Soule, Hiffsa Taj, Claire McAvoy, Chaitanya Iragavarapu, Gregory Monohan, Reinhold Munker, Fevzi Yalniz, Ayman Qasrawi, Reshma Ramlal

Blood (2023) 142 (Supplement 1): 5864.

https://doi.org/10.1182/blood-2023-185356

Published: 2023

Journal Articles

Correlation between Number of Molecular Mutations and Outcomes in De Novo Acute Myeloid Leukemia

Zena Chahine, Xitong Zhou, Anna Johnson, Trevor Morris, Ashley Soule, Hiffsa Taj, Claire McAvoy, Chaitanya Iragavarapu, Reinhold Munker, Gregory Monohan, Fevzi Yalniz, Ayman Qasrawi, Reshma Ramlal

Blood (2023) 142 (Supplement 1): 5878.

https://doi.org/10.1182/blood-2023-188007

Published: 2023

Journal Articles

Distinct Clinical and Genetic Features of Acute Myeloid Leukemia (AML) in Obese Vs. Non-Obese Patients: A Comparative Study

Anna Johnson, Zena Chahine, Trevor Morris, Ashley Soule, Hiffsa Taj, Claire McAvoy, Xitong Zhou, Chaitanya Iragavarapu, Reinhold Munker, Gregory Monohan, Reshma Ramlal, Ayman Qasrawi, Fevzi Yalniz

Blood (2023) 142 (Supplement 1): 2858.

https://doi.org/10.1182/blood-2023-189764

Published: 2023

Journal Articles

Adverse Prognostic Factors in Adult Secondary Hemophagocytic Lymphohistiocytosis: Results from Two Tertiary Academic Centers

Omar Abughanimeh, MD, Ayman Qasrawi, MD, James O. Armitage, MD, Julie M. Vose, MD MBA, Gerhard C. Hildebrandt, MD, Muhamed Baljevic, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137038

Published: 2020

Journal Articles

Acute Undifferentiated Leukemia

Ayman Qasrawi, MD, Gomez Victor, MD, Reinhold Munker, MD

Blood (2019) 134 (Supplement_1): 3847.

https://doi.org/10.1182/blood-2019-123274

Published: 2019

Journal Articles

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

Ayman Qasrawi, MD, Richard L O'Neal, MD, Maxwell M. Krem, MD PhD, Gregory Monohan, MD, Reinhold Munker, MD, Gerhard C. Hildebrandt, MD

Blood (2019) 134 (Supplement_1): 4735.

https://doi.org/10.1182/blood-2019-127687

Published: 2019

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

TBI based VS chemotherapy based myeloablative conditioning in T cell replete haploidentical transplant

Ziftomenib in combination with venetoclax and azacitidine in newly diagnosed NPM1-m acute myeloid leukemia: Phase 1b results from KOMET-007

Beyond age: Genomic features and treatment outcomes in older versus younger adults with Acute Myeloid Leukemia

Outcomes with liposomal daunorubicin/cytarabine – a single-center experience

Genetic risk model to predict outcomes for AML treated with HMA and venetoclax

Prognostic impact of co-occurring mutations in NPM1-mutated Acute Myeloid Leukemia

Impact of induction regimen and co-mutations on outcomes in AML with myelodysplasia-related changes

Efficacy and safety of clia plus venetoclax as salvage therapy for relapsed or refractory Acute Myeloid Leukemia

Appropriate Timing of Allogeneic Bone Marrow Transplant in Patients with Myelodysplastic Syndrome

Outcomes of Rituximab and Bendamustine Induction Regimen VS Cytarabine-Based Induction for Patients with Mantle Cell Lymphoma

Gilteritinib Results in Higher Remission and Transplant Rates Than Midostaurin but Does Not Increase the Post-Induction Mutational MRD Negative Rate: Results of the Phase 2 Randomized Precog 0905 Study in Newly Diagnosed FLT3 Mutated AML

Efficacy of Tagraxofusp in Blastic Plasmacytoid Dendritic Cell Neoplasm, an Interrupted Time Series Analysis

Hyperbaric Oxygen (HBO) Effects on Blood Count Recovery and Post Transplant Outcomes Following High-Dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma: Final Analysis of the Multicenter Phase II Randomized Clinical Trial

Hyperbaric Oxygen (HBO) Effects on Blood Count Recovery and Post-Transplant Outcomes Following High-Dose Therapy and Autologous HSPC Transplantation for Multiple Myeloma: A Multicenter Phase II Randomized Clinical Trial

A Comparison of Somatic Mutations and ELN Classification in De Novo Acute Myeloid Leukemia between Appalachian and Non-Appalachian Kentucky

Correlation between Number of Molecular Mutations and Outcomes in De Novo Acute Myeloid Leukemia

Distinct Clinical and Genetic Features of Acute Myeloid Leukemia (AML) in Obese Vs. Non-Obese Patients: A Comparative Study

Adverse Prognostic Factors in Adult Secondary Hemophagocytic Lymphohistiocytosis: Results from Two Tertiary Academic Centers

Acute Undifferentiated Leukemia

Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only